pd168393 has been researched along with Allergic Contact Dermatitis in 1 studies
PD 168393 : A member of the class of quinazolines carrying bromoanilino and acrylamido substituents at positions 4 and 6 respectively.
| Excerpt | Relevance | Reference |
|---|---|---|
| "PD168393, an EGFRI, was applied topically to the ear skin of mice with or without mast cell deficiency." | 1.37 | Phenylbutyrate suppresses distinct skin reactions that are enhanced by blockade of epidermal growth factor receptor signaling. ( Chung, YL; Pui, NN, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chung, YL | 1 |
| Pui, NN | 1 |
1 other study available for pd168393 and Allergic Contact Dermatitis
| Article | Year |
|---|---|
Phenylbutyrate suppresses distinct skin reactions that are enhanced by blockade of epidermal growth factor receptor signaling.
Topics: Administration, Cutaneous; Animals; Anti-Inflammatory Agents; Cells, Cultured; Chemokine CCL2; Derma | 2011 |